Wear it on Your Sleeve: How Sensors and Wearables Help Drive Richer Insights on Intervention Effects Date Published: Aug 17, 2020 Article Although clinical outcome assessments (COAs) are invaluable in clinical trial research, sensors and wearables are becoming increasingly popular for their ability to s to supplement patient self-reports with objective data. In this PharmVOICE article, Signant Health’s Bill Byrom details why sponsor should consider using sensors and wearables and provides examples of how they can be applied. Capable of being worn passively by study participants, these devices also benefit study participants. Readers will discover how they make participation easier and safer through continuous, at-home monitoring. Click to read how Signant Health is harnessing the technology’s potential to help top pharma companies improve their clinical trials. Read More Share: LinkedInTweet Recommended Resources Article Conversation with Bill Byrom & Mariana Fontana: Measuring Aspects of Health in Heart Failure Research Dr. Bill Byrom, Principal, eCOA Science at Signant Health, recently had the pleasure of sitting downwith Professor Marianna Fontana, Professor... Download Now Article Conversation with Bill Byrom & Julian Gillmore: Increasing the Usefulness of COAs in Heart Failure Research Dr. Bill Byrom, Principal, eCOA Science at Signant Health, recently had the pleasure of sitting downwith Professor Julian Gillmore, Professor... Download Now Article Optimal COA Measurement Strategy in Modern Oncology Trials The inclusion of patient-reported outcomes (PRO) data in oncology medication labeling in the U.S. has been comparatively limited. Recent FDA... Read Now